FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION THAT HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM) INJECTABLE, 200 UNITS/100 MILLILITERS, AND TWO OTHER DRUG PRODUCTS WERE NOT WITHDRAWN FROM SALE FOR REASONS OF SAFETY OR EFFECTIVENESS

WASHINGTON, Aug. 4 -- Food and Drug Administration has issued a notice called: Determination That HEPARIN SODIUM 1, 000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (Heparin Sodium) Injectable, 200 Units/100 Milliliters, and Two Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness.

The notice was published in the Federal Register on Aug. 4 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) has determined that HEPARIN SODIUM 1, 000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (heparin sodium) injectable, 200 units/100 milliliters (mL); HEPARIN SODIUM 2, 000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTI...